- Home
- HROW vs BDJ Comparison
HROW vs BDJ Comparison
Compare HROW & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- BDJ
- Stock Information
- Founded
- HROW 1998
- BDJ 2005
- Country
- HROW United States
- BDJ United States
- Employees
- HROW 382
- BDJ N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- BDJ Finance Companies
- Sector
- HROW Health Care
- BDJ Finance
- Exchange
- HROW Nasdaq
- BDJ Nasdaq
- Market Cap
- HROW 1.4B
- BDJ 1.6B
- IPO Year
- HROW N/A
- BDJ N/A
- Fundamental
- Price
- HROW $39.22
- BDJ $9.05
- Analyst Decision
- HROW Strong Buy
- BDJ
- Analyst Count
- HROW 7
- BDJ 0
- Target Price
- HROW $64.67
- BDJ N/A
- AVG Volume (30 Days)
- HROW 671.7K
- BDJ 561.6K
- Earning Date
- HROW 08-11-2025
- BDJ 01-01-0001
- Dividend Yield
- HROW N/A
- BDJ 8.85%
- EPS Growth
- HROW N/A
- BDJ N/A
- EPS
- HROW N/A
- BDJ N/A
- Revenue
- HROW $227,661,000.00
- BDJ N/A
- Revenue This Year
- HROW $46.17
- BDJ N/A
- Revenue Next Year
- HROW $39.97
- BDJ N/A
- P/E Ratio
- HROW N/A
- BDJ N/A
- Revenue Growth
- HROW 47.69
- BDJ N/A
- 52 Week Low
- HROW $20.85
- BDJ $6.91
- 52 Week High
- HROW $59.23
- BDJ $8.66
- Technical
- Relative Strength Index (RSI)
- HROW 62.35
- BDJ 62.15
- Support Level
- HROW $37.09
- BDJ $8.95
- Resistance Level
- HROW $39.67
- BDJ $9.05
- Average True Range (ATR)
- HROW 2.41
- BDJ 0.07
- MACD
- HROW 0.10
- BDJ 0.02
- Stochastic Oscillator
- HROW 87.23
- BDJ 100.00
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About BDJ Blackrock Enhanced Equity Dividend Trust
BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.